| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
I.M.D. International Medical Devices S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.44 |
| 52 Week High | €1.99 |
| 52 Week Low | €1.14 |
| Beta | 0 |
| 1 Month Change | 11.63% |
| 3 Month Change | -11.11% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -28.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| X74 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.7% | -0.6% | -1.4% |
| 1Y | n/a | -9.6% | 2.2% |
Return vs Industry: Insufficient data to determine how X74 performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how X74 performed against the German Market.
Price Volatility
| X74 volatility | |
|---|---|
| X74 Average Weekly Movement | 5.8% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: X74 has not had significant price volatility in the past 3 months.
Volatility Over Time: X74's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 116 | Aniello Aliberti | www.imdgroup.it |
I.M.D. International Medical Devices S.p.A. designs, develops, manufactures, and markets a range of diagnostic systems with X-ray technology. It also provides components for clinical applications in the radiology and medical fields; and monoblocks, RX generators, and control systems, as well as imagining devices used in orthopaedic, urology, emergency rooms, and operating theatres. I.M.D.
I.M.D. International Medical Devices S.p.A. Fundamentals Summary
| X74 fundamental statistics | |
|---|---|
| Market cap | €26.33m |
| Earnings (TTM) | €2.22m |
| Revenue (TTM) | €38.49m |
11.9x
P/E Ratio0.7x
P/S RatioIs X74 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| X74 income statement (TTM) | |
|---|---|
| Revenue | €38.49m |
| Cost of Revenue | €28.12m |
| Gross Profit | €10.36m |
| Other Expenses | €8.15m |
| Earnings | €2.22m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 26.93% |
| Net Profit Margin | 5.76% |
| Debt/Equity Ratio | 6.8% |
How did X74 perform over the long term?
See historical performance and comparison